This inventor holds 5 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Teijin Limited, Japan Science and Technology Corporation, Kyoto University. Active years: 1980-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,605 
1 out of 373 
1 out of 872 
Years Active: 1980-2016
Title: Shunichi Takeda: Innovator in Pharmaceutical Research
Introduction
Shunichi Takeda is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of pharmaceutical research, particularly in the development of cancer treatments. With a total of 5 patents to his name, Takeda's work has the potential to impact the lives of many patients.
Latest Patents
One of Takeda's latest patents is a pharmaceutical composition for use in the prevention or treatment of cancer. This invention focuses on Abacavir, a nucleoside analog reverse transcriptase inhibitor, which has demonstrated anti-cancer activity on ATL cells in vitro without inhibiting DNA replication of normal cells. Abacavir or its pharmaceutically acceptable derivatives are proposed as active ingredients in compositions aimed at treating cancers with impaired DNA repair systems, such as breast cancer and adult T-cell leukemia. Another notable patent is a method for generating diversity, which involves preparing an antibody-producing cell line capable of directed constitutive hypermutation of a specific nucleic acid region. This method includes screening a clonal cell population for V gene diversity and selecting cells that exhibit a higher rate of V gene mutation compared to other genes.
Career Highlights
Throughout his career, Shunichi Takeda has worked with esteemed organizations such as Teijin Limited and the Medical Research Council. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research endeavors.
Collaborations
Takeda has collaborated with notable individuals in his field, including Osamu Wada and Yoshiyuki Sasaki. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Shunichi Takeda's innovative work in pharmaceutical research, particularly in cancer treatment, showcases his dedication to improving healthcare outcomes. His patents reflect a commitment to scientific advancement and the potential to change lives through effective medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile